Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Fungal infections are a major contributor to infectious disease-related deaths across the
globe. Candida species are among the most common causes of invasive mycotic disease …
globe. Candida species are among the most common causes of invasive mycotic disease …
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
Cryptococcus spp., in particular Cryptococcus neoformans and Cryptococcus gattii, have an
enormous impact on human health worldwide. The global burden of cryptococcal meningitis …
enormous impact on human health worldwide. The global burden of cryptococcal meningitis …
[HTML][HTML] Roles of Hsp90 in Candida albicans morphogenesis and virulence
Highlights•Hsp90 is a molecular chaperone that modulates the function of many client
proteins.•Morphogenesis is an important Candida albicans virulence trait.•Hsp90 regulates …
proteins.•Morphogenesis is an important Candida albicans virulence trait.•Hsp90 regulates …
Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies
H Lu, T Hong, Y Jiang, M Whiteway, S Zhang - Advanced Drug Delivery …, 2023 - Elsevier
Candidiasis is an infection caused by fungi from a Candida species, most commonly
Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on …
Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on …
Candida albicans targets that potentially synergize with fluconazole
H Lu, M Shrivastava, M Whiteway… - Critical reviews in …, 2021 - Taylor & Francis
Fluconazole has characteristics that make it widely used in the clinical treatment of C.
albicans infections. However, fluconazole has only a fungistatic activity in C. albicans …
albicans infections. However, fluconazole has only a fungistatic activity in C. albicans …
Pan-and isoform-specific inhibition of Hsp90: Design strategy and recent advances
J Yu, C Zhang, C Song - European Journal of Medicinal Chemistry, 2022 - Elsevier
In the past few decades, the development of heat shock protein 90 (Hsp90) inhibitors for
cancer treatment has not stopped. About twenty compounds have been evaluated in the …
cancer treatment has not stopped. About twenty compounds have been evaluated in the …
[HTML][HTML] Development and research progress of anti-drug resistant fungal drugs
X Cui, L Wang, Y Lue, C Yue - Journal of Infection and Public Health, 2022 - Elsevier
With the widespread use of immunosuppressive agents and the increase in patients with
severe infections, the incidence of fungal infections worldwide has increased year by year …
severe infections, the incidence of fungal infections worldwide has increased year by year …
The role of Candida albicans stress response pathways in antifungal tolerance and resistance
Human fungal pathogens are the causative agents of devastating diseases across the
globe, and the increasing prevalence of drug resistance threatens to undermine the already …
globe, and the increasing prevalence of drug resistance threatens to undermine the already …
New antifungal strategies: drug combination and co-delivery
P Zhu, Y Li, T Guo, S Liu, RJ Tancer, C Hu… - Advanced Drug Delivery …, 2023 - Elsevier
The growing occurrence of invasive fungal infections and the mounting rates of drug
resistance constitute a significant menace to human health. Antifungal drug combinations …
resistance constitute a significant menace to human health. Antifungal drug combinations …
Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans
C Li, J Tu, G Han, N Liu, C Sheng - European journal of medicinal chemistry, 2022 - Elsevier
Clinical treatment of candidiasis has suffered from increasingly severe drug resistance and
limited efficacy. Thus, novel strategies to deal with drug resistance are highly desired to …
limited efficacy. Thus, novel strategies to deal with drug resistance are highly desired to …